3rd Quarter - Report
DENDREON PHARMACEUTICALS, LLC for DENDREON PHARMACEUTICALS, LLC
Income
—
Expenses
$120,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Medicare Part B drug payment reform Elijah E. Cummings Lower Drug Costs Now Act (HR 3) Prescription Drug Pricing Reduction Act of 2020 (S 4199) Lower Costs, More Cures Act of 2021 (HR 19)(S 3129) Build Back Better Act (HR 5376)
Foreign entity interest: Dendreon, a subsidiary of Nanjing Xinjiekou Department Store, Co. Ltd. in China.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW SAELENS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.